Purdue Halts FDA Review Of Abuse-Resistant OxyContin Label
Purdue Pharma LP has withdrawn an application to include more information on a label for a tamper-resistant version of its oxycodone painkiller OxyContin ahead of a review of the label by...To view the full article, register now.
Already a subscriber? Click here to view full article